Anders Jack 4
4 · Revolution Medicines, Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-25$17.00/sh+5,418$92,106→ 116,412 total - Sale
Common Stock
2025-11-25$74.00/sh−5,418$400,932→ 110,994 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−5,418→ 0 totalExercise: $17.00From: 2024-02-12Exp: 2030-02-11→ Common Stock (5,418 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]Includes 48,275 restricted stock units.